Ph.D. Michael Exton

Insider Reports History

Location
Spring, TX
Signature
/s/ Michael Exton, Ph.D.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ph.D. Michael Exton:

Company Role Class Num Shares Value Price $ Report Date Ownership
LEXICON PHARMACEUTICALS, INC. Chief Executive Officer, Director Restricted Stock Units 1,006,527 $1,011,559 $0.6700 28 Feb 2026 Direct
LEXICON PHARMACEUTICALS, INC. Chief Executive Officer, Director Common Stock 298,432 $438,695 $1.47 28 Feb 2026 Direct
LEXICON PHARMACEUTICALS, INC. Chief Executive Officer, Director Stock Option (Right to Buy) 1,293,670 12 Feb 2026 Direct

Insider Reports Filed by Ph.D. Michael Exton

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LXRX LEXICON PHARMACEUTICALS, INC. 28 Feb 2026 3 -$301,102 4 Chief Executive Officer, Director 03 Mar 2026, 07:15
LXRX LEXICON PHARMACEUTICALS, INC. 12 Feb 2026 2 $0 4 Chief Executive Officer, Director 17 Feb 2026, 16:05
LXRX LEXICON PHARMACEUTICALS, INC. 13 Feb 2025 2 $0 4 Chief Executive Officer, Director 18 Feb 2025, 16:16
LXRX LEXICON PHARMACEUTICALS, INC. 08 Jul 2024 1 $0 4 Chief Executive Officer, Director 08 Jul 2024, 17:27
LXRX LEXICON PHARMACEUTICALS, INC. 08 Jul 2024 0 $0 3 Chief Executive Officer, Director 08 Jul 2024, 17:26